|
TW200301123A
(en)
|
2001-12-21 |
2003-07-01 |
Astrazeneca Uk Ltd |
New use
|
|
WO2004026306A2
(en)
|
2002-09-18 |
2004-04-01 |
Pfizer Products Inc. |
Pyrazole derivatives as transforming growth factor (tgf) inhibitors
|
|
JP4896518B2
(ja)
|
2002-12-13 |
2012-03-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
ニコチンアミド系キナーゼ阻害薬
|
|
AU2003297460A1
(en)
|
2002-12-19 |
2004-07-14 |
Scios, Inc. |
TREATMENT OF OBESITY AND ASSOCIATED CONDITIONS WITH TGF-Beta INHIBITORS
|
|
EP1644365A2
(en)
|
2003-07-02 |
2006-04-12 |
Biofocus Discovery Ltd |
Pyrazine and pyridine derivatives as rho kinase inhibitors
|
|
US20050032869A1
(en)
|
2003-07-08 |
2005-02-10 |
Pharmacia Italia S.P.A. |
Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
US20090196912A1
(en)
|
2004-07-30 |
2009-08-06 |
Gpc Botech Ag |
Pyridinylamines
|
|
DK1789044T3
(da)
|
2004-09-06 |
2010-12-06 |
Basilea Pharmaceutica Ag |
Phenylaminopyridiner og phenylaminopyraziner
|
|
HN2005000795A
(es)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
Pirimidinas como antagonistas del receptor de prostaglandina d2
|
|
WO2007084667A2
(en)
|
2006-01-19 |
2007-07-26 |
Osi Pharmaceutical, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
BRPI0807961A2
(pt)
|
2007-02-13 |
2017-05-16 |
Pharmacopeia Llc |
agonista de alfa2c adrenorreceptor funcionalmente seletivos.
|
|
GB0705566D0
(en)
|
2007-03-23 |
2007-05-02 |
Univ Dundee |
Method of treating learning impairment in down's syndrome subjects
|
|
EP2178537A4
(en)
|
2007-07-19 |
2011-08-17 |
Merck Sharp & Dohme |
BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
|
|
EP2265603B1
(en)
|
2008-03-13 |
2014-05-07 |
The General Hospital Corporation |
Inhibitors of the bmp signaling pathway
|
|
US20100173931A1
(en)
*
|
2009-01-06 |
2010-07-08 |
Osteogenex Inc. |
Harmine derivatives for reducing body weight
|
|
WO2010123583A2
(en)
|
2009-04-24 |
2010-10-28 |
University Of Tennessee Research Foundation |
1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof
|
|
AU2010247412A1
(en)
|
2009-05-15 |
2011-11-24 |
Novartis Ag |
5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or CYP11B1
|
|
WO2010135589A2
(en)
|
2009-05-20 |
2010-11-25 |
Sakura Properties, Llc |
Dietary supplement drink for delivery of resveratrol and other polyphenols
|
|
JP2011006408A
(ja)
|
2009-05-29 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
神経栄養因子の活性が関与する疾患の治療または予防剤
|
|
CN102791134B
(zh)
|
2009-12-04 |
2015-04-22 |
魄金莱默有限公司 |
用多巴胺再摄取抑制剂及类似物治疗糖尿病症状和延迟或预防糖尿病相关病理学病况的方法
|
|
WO2011075665A2
(en)
|
2009-12-18 |
2011-06-23 |
President And Fellows Of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|
|
US20130102627A1
(en)
|
2010-04-09 |
2013-04-25 |
The Brigham And Women's Hospital, Inc. |
Acridines As Inhibitors Of Haspin And DYRK Kinases
|
|
WO2011133795A2
(en)
|
2010-04-22 |
2011-10-27 |
The Brigham And Women's Hospital, Inc. |
Beta-carbolines as inhibitors of haspin and dyrk kinases
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
MX341025B
(es)
|
2010-05-05 |
2016-08-04 |
Boehringer Ingelheim Int Gmbh * |
Terapia de combinacion.
|
|
US9168247B2
(en)
|
2010-06-25 |
2015-10-27 |
Facultes Universitaires Notre Dame De La Paix |
Beta carboline derivatives useful in the treatment of proliferative disorders
|
|
AU2011290123B2
(en)
|
2010-08-09 |
2016-11-10 |
Takeda Pharmaceutical Company Limited |
Method of producing pancreatic hormone-producing cells
|
|
US20130165474A1
(en)
|
2010-08-17 |
2013-06-27 |
Travis Dunckley |
Compounds that inhibit tau phosphorylation
|
|
KR102006749B1
(ko)
|
2011-08-19 |
2019-08-02 |
디악쏘니 |
Dyrk1 억제제 및 이의 용도
|
|
EP2763976B1
(en)
|
2011-10-05 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
CN103070862A
(zh)
|
2011-10-25 |
2013-05-01 |
新疆华世丹药物研究有限责任公司 |
去氢骆驼蓬碱衍生物在制备抗菌药物中的应用
|
|
WO2013119518A1
(en)
|
2012-02-06 |
2013-08-15 |
The Regents Of The University Of California |
Small molecules for islet expansion
|
|
SG11201406584TA
(en)
|
2012-04-24 |
2014-11-27 |
Vertex Pharma |
Dna-pk inhibitors
|
|
AU2013284460A1
(en)
|
2012-06-27 |
2015-01-29 |
Dmnomore |
CTLA4 fusion proteins for the treatment of diabetes
|
|
CN105142621A
(zh)
|
2012-10-24 |
2015-12-09 |
国家健康科学研究所 |
用于预防或治疗糖尿病和促进β-细胞存活的TPL2激酶抑制剂
|
|
JP2016500080A
(ja)
|
2012-11-26 |
2016-01-07 |
新疆華世丹薬物研究有限責任公司 |
ビスβ−カルボリン系化合物、その製造方法、医薬組成物および用途
|
|
JPWO2014058080A1
(ja)
|
2012-11-30 |
2016-09-05 |
国立研究開発法人理化学研究所 |
体細胞のリプログラミングを亢進させる方法、及び細胞作製キット
|
|
CN102977096B
(zh)
|
2012-12-07 |
2014-12-17 |
中国药科大学 |
具有靶向特性的去氢骆驼蓬碱衍生物的抗肿瘤前药
|
|
MX2015007097A
(es)
|
2012-12-10 |
2015-09-29 |
Hoffmann La Roche |
Nuevas fenil-piridinas/pirazinas bi-anulares para el tratamiento de cancer.
|
|
US20150174034A1
(en)
|
2013-03-13 |
2015-06-25 |
Avon Products, Inc. |
Tyrosinase inhibitors
|
|
SI2968284T1
(sl)
|
2013-03-14 |
2021-08-31 |
Osteoqc Inc. |
Alkil-amin harmin derivati za pospeševanje rasti kosti
|
|
WO2014151682A1
(en)
|
2013-03-14 |
2014-09-25 |
Icahn School Of Medicine At Mount Sinai |
Pyrimidine compounds as kinase inhibitors
|
|
CN105555785B
(zh)
|
2013-06-18 |
2019-03-01 |
4Sc股份公司 |
作为dyrk激酶抑制剂的2,3-二氢苯并呋喃-5-基化合物
|
|
GB2519623A
(en)
|
2013-06-18 |
2015-04-29 |
4Sc Discovery Gmbh |
Method of inhibiting DYRK1B
|
|
US9725463B2
(en)
|
2013-06-21 |
2017-08-08 |
Lupin Limited |
Substituted heterocyclic compounds as CRAC modulators
|
|
ES2529865B8
(es)
|
2013-07-25 |
2016-01-22 |
Fundación Para La Investigación Biomédica Del Hospital Universitario La Paz (Fibhulp) |
USO DE COMPUESTOS DERIVADOS DE SALES DE PIRIDAZINO[1',6':1,2]PIRIDO[3,4-b]INDOLINIO COMO AGENTES ANTIINFLAMATORIOS
|
|
SI3057959T1
(en)
|
2013-10-17 |
2018-07-31 |
Vertex Pharmaceuticals Incorporated |
DNA-PK INHIBITORS
|
|
JP6767875B2
(ja)
|
2014-04-08 |
2020-10-14 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Tgf−ベータ阻害剤としての2,3−二置換ピリジン化合物および使用方法
|
|
US20170280720A1
(en)
|
2014-09-17 |
2017-10-05 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
|
WO2016064676A1
(en)
|
2014-10-21 |
2016-04-28 |
Genzada Pharmaceuticals Llc |
Human therapeutic agents
|
|
ES2985135T3
(es)
|
2014-12-18 |
2024-11-04 |
Harvard College |
Procedimientos para generar células ß derivadas de células madre y usos de las mismas
|
|
ES2820768T3
(es)
|
2015-04-03 |
2021-04-22 |
Xoma Technology Ltd |
Tratamiento del cáncer usando inhibidores de TGF-beta y PD-1
|
|
US11332716B2
(en)
|
2015-07-27 |
2022-05-17 |
The Regents Of The University Of California |
Methods and compositions for producing pancreatic beta cells
|
|
AU2016315881B2
(en)
|
2015-09-03 |
2019-09-19 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of DYRK1A and uses thereof
|
|
CR20180323A
(es)
|
2015-11-20 |
2018-08-06 |
Idorsia Pharmaceuticals Ltd |
Derivados de indol n-sustituídos como moduladores de los receptores de pge2
|
|
CN105884767B
(zh)
|
2015-11-24 |
2018-01-19 |
西华大学 |
9‑位取代的吡啶并[3,4‑b]吲哚衍生物及其制备方法和作为SIRT蛋白抑制剂的用途
|
|
EP3389720A1
(en)
|
2015-12-18 |
2018-10-24 |
The General Hospital Corporation |
Polyacetal polymers, conjugates, particles and uses thereof
|
|
US10487087B2
(en)
|
2015-12-30 |
2019-11-26 |
Vanderbilt University |
Positive allosteric modulators of the GLP-1 receptor
|
|
WO2017168245A1
(en)
|
2016-04-01 |
2017-10-05 |
University Of Limerick |
Pharmaceutical compositions and methods for the treatment of diabetes
|
|
WO2017197151A1
(en)
|
2016-05-11 |
2017-11-16 |
Emory University |
Phosphotidylinositol 3-kinase inhibitors
|
|
WO2018081401A1
(en)
|
2016-10-26 |
2018-05-03 |
Ichan School Of Medicine At Mount Sinai |
Method for increasing cell proliferation in pancreatic beta cells, treatmen t method.and composition
|
|
EP3318563A1
(en)
|
2016-11-07 |
2018-05-09 |
Sanofi |
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
|
|
US11279703B2
(en)
|
2016-12-01 |
2022-03-22 |
Aptose Biosciences Inc. |
Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereof
|
|
EA201992676A1
(ru)
|
2017-05-18 |
2020-05-06 |
Идорсия Фармасьютиклз Лтд |
Фенильные производные в качестве модуляторов pge2 рецепторов
|
|
WO2019100062A1
(en)
|
2017-11-20 |
2019-05-23 |
Ichan School Of Medicine At Mount Sinai |
Kinase inhibitor compounds and compositions and methods of use
|
|
JP2021510153A
(ja)
|
2018-01-05 |
2021-04-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
膵臓ベータ細胞の増殖を増加させる方法、治療方法、および組成物
|
|
ES3038913T3
(en)
|
2018-03-20 |
2025-10-15 |
Icahn School Med Mount Sinai |
Beta-carboline derivatives as dyrk1a inhibitors for the treatment of e.g. diabetes
|
|
CA3124700A1
(en)
|
2018-12-31 |
2020-07-09 |
Icahn School Of Medicine At Mount Sinai |
Kinase inhibitor compounds and compositions and methods of use
|
|
CA3124353A1
(en)
|
2018-12-31 |
2020-07-09 |
Icahn School Of Medicine At Mount Sinai |
Kinase inhibitor compounds and compositions and methods of use
|
|
US20230234935A1
(en)
|
2020-06-26 |
2023-07-27 |
Icahn School Of Medicine At Mount Sinai |
Kinase inhibitor compounds and compositions and methods of use
|